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Parkinson’s disease (PD) is a condition which progressively damages parts of the brain, 
leading to difficulties with physical movement, alongside additional physical and mental 
symptoms. PD can impact on the wellbeing of both the people experiencing the condition and 
their caregivers. Therefore, this thesis firstly aimed to address whether psychosocial 
interventions for people living with PD and caregivers may have psychological and any 
additional benefits. A review was undertaken of studies which delivered psychosocial 
interventions to both people living with PD and caregivers. This review found that 
psychosocial interventions, which include both people living with PD and caregivers, may 
provide psychological benefits for people living with PD. There was very limited evidence to 
suggest benefits for caregivers participating in these psychosocial interventions. This review 
highlights that research into psychosocial interventions for people living with PD and their 
caregivers has grown over the last decade. Nevertheless, more research of a greater quality is 
required to draw conclusions of the benefits from psychosocial interventions delivered to 
people living with PD alongside caregivers.  
 
This thesis secondly aimed to explore what may contribute to people living with PD and 
caregivers adjusting better to living with the disease. Therefore, a postal survey was 
undertaken by people living with PD and their caregivers. It was found that beliefs participants 
living with PD have towards their illness, the number of coping responses they engage with, 
and how compassionate they are to themselves, are all associated with how successful their 
adjustment is living with PD. Due to the small sample size, it was not possible to establish 
what factors may predict how well caregivers adjust to supporting people living with PD. 
However, the findings do indicate it would be beneficial to undertake further research of a 
larger and more representative sample to establish the role of illness beliefs, coping responses 




Table of Contents 
Lay summary ................................................................................................................ 1 
Figures and Tables ....................................................................................................... 3 
Thesis Abstract ............................................................................................................. 5 
 
Chapter 1: Systematic Review .................................................................................. 6 
Abstract ........................................................................................................................ 7 
Introduction .................................................................................................................. 8 
Objective................................................................................................................. 11 
Methods ...................................................................................................................... 11 
Protocol................................................................................................................... 11 
Eligibility Criteria ................................................................................................... 12 
Literature Search Strategy ...................................................................................... 13 
Data Collection and Analysis ................................................................................. 14 
Results ........................................................................................................................ 16 
Study Selection ....................................................................................................... 16 
Characteristics of Included Studies ........................................................................ 17 
Appraisal of Methodological Quality ..................................................................... 25 
Key Findings .......................................................................................................... 27 
Discussion .................................................................................................................. 40 
Strengths and Limitations of Review ..................................................................... 46 
Implications for Research ....................................................................................... 47 
Conclusions ............................................................................................................ 48 
Clinical Messages ................................................................................................... 48 
References .................................................................................................................. 49 
 
Chapter 2. Empirical Paper .................................................................................... 57 
Abstract ...................................................................................................................... 58 
Introduction ................................................................................................................ 59 
Aims ....................................................................................................................... 63 
Methods ...................................................................................................................... 64 
Design ..................................................................................................................... 64 




Eligibility of Participants ........................................................................................ 65 
Recruitment ............................................................................................................ 66 
Materials ................................................................................................................. 67 
Statistical Analysis ................................................................................................. 71 
Results ........................................................................................................................ 73 
Descriptive Statistics .............................................................................................. 73 
Control Variables.................................................................................................... 76 
Correlation Analysis ............................................................................................... 76 
Hierarchical Multiple Regression Analysis ............................................................ 78 
Discussion .................................................................................................................. 87 
Strengths and Limitations of Study ........................................................................ 91 
Clinical Implications .............................................................................................. 92 
Conclusions ............................................................................................................ 94 
Declaration of Interests........................................................................................... 95 
References .................................................................................................................. 95 
 
Appendices .............................................................................................................. 102 
Appendix 1. Clinical Rehabilitation Author Guidelines ...................................... 103 
Appendix 2. Studies excluded due to duplication of Participant Data ................. 111 
Appendix 3. Quality Appraisal Tools and Scoring .............................................. 112 
Appendix 4. Psychology & Health Author Guidelines ........................................ 114 
Appendix 5. Research Ethics Committee Approval ............................................. 120 
Appendix 6. Research & Development Approval ................................................ 122 
Appendix 7. Protocol ............................................................................................ 127 
Appendix 8. Participant Information Sheet – Participant with PD ...................... 138 
Appendix 9. Participant Information Sheet – Caregiver ...................................... 141 
Appendix 10. Consent Form – Participant with PD ............................................. 144 
Appendix 11. Consent Form – Caregiver ............................................................. 146 
Appendix 12. Thesis Portfolio References ........................................................... 148 
 




Figures and Tables 
 
Chapter 1. Systematic Review 
Figure 1. PRISMA Flowchart .................................................................................... 18 
Table 1. Characteristics of Studies ............................................................................. 19 
Table 2. Methodological Quality Appraisal Ratings.................................................. 26 
Table 3. Summary of Study Results ........................................................................... 36 
 
Chapter 2. Empirical Paper 
Table 4. Demographic and Clinical Information of Participants with PD ................. 74 
Table 5. Demographic Information of Caregivers ..................................................... 74 
Table 6. Means for Participants with PD and Caregivers .......................................... 75 
Table 7. Correlation Analysis for Participants with PD ............................................. 77 
Table 8. Correlation Analysis for Caregivers ............................................................ 77 
Table 9. Hierarchical regression to predict anxiety in participants with PD ............. 80 
Table 10. Hierarchical regression to predict depression in participants with PD ...... 81 
Table 11. Hierarchical regression to predict QoL in participants with PD ................ 82 
Table 12. Hierarchical regression to predict anxiety in caregivers ............................ 83 
Table 13. Hierarchical regression to predict depression in caregivers....................... 84 











This thesis comprises of a systematic review and an empirical study aimed to gain a greater 
understanding of the psychological needs of both people living with Parkinson’s disease (PD), 
their caregivers, and how these needs can be met. The systematic review aimed to evaluate the 
effectiveness of psychosocial interventions, where people living with PD and their caregivers 
are involved in the intervention (dyad-based), on psychological and additional outcomes 
measured. The review included 13 studies which met predefined eligibility criteria. Due to 
varied methodological quality of the studies, this review to an extent suggests that dyad-based 
psychosocial interventions may provide psychological benefits for people living with PD. 
Whereas, there was no substantive evidence to suggest dyad-based psychosocial interventions 
are effective for caregivers. More high-quality research is required to conclusively establish 
the effectiveness of these interventions for both people living with PD and their caregivers. 
The empirical study extended previous research examining the relationship between illness 
beliefs and coping with psychological adjustment (in terms of anxiety, depression and quality 
of life) in people living with PD and caregivers, whilst developing research in to the role of 
self-compassion within this process. A cross-sectional survey design with participants living 
with PD (N=66) and their caregivers (N=24) with the following measures was utilised; Brief 
COPE, Brief-Illness Perception Questionnaire, Self-Compassion Scale, Hospital Anxiety and 
Depression Scale, Parkinson’s disease Questionnaire 8-item and Adult Carer Quality of Life 
Questionnaire. The results of the study provided further evidence for the relationship between 
illness beliefs and psychological adjustment outcomes in people living with PD. In addition, 
the study provided preliminary evidence of a relationship between self-compassion and 
psychological adjustment outcomes of psychological distress in people living with PD. Further 
research of a larger and more representative sample is required to establish the role of illness 
beliefs, coping responses and self-compassion in psychological adjustment in both people 
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Objectives: This systematic review aimed to evaluate the effectiveness of psychosocial 
interventions, where people living with Parkinson’s disease (PD) and caregivers are involved 
in the intervention (dyad-based), on psychological and additional outcomes measured for 
people living with PD and caregivers. 
Data sources: The following were systematically searched from database inception to October 
2018; MEDLINE, PsycINFO, PsycARTICLES, ProQuest, Scopus, Teacher Reference Centre, 
Education Source, Cochrane Central Register of Controlled Trials, ERIC, EMBASE, ASSIA. 
Review methods: A protocol was registered with PROSPERO (CRD42018112992). All study 
designs of dyad-based psychosocial interventions were reviewed where psychological 
outcomes were reported for participants living with PD and caregivers. The Effective Public 
Health Practice Project Quality Assessment Tool and customised quality criteria were applied 
to assess methodological quality of included studies, with a proportion (70%) assessed for 
inter-rater reliability. 
Results: Thirteen studies were included in the review. Studies were predominantly Cognitive 
Behavioural Therapy (CBT) or CBT-informed interventions, with heterogeneity in design, 
delivery type, caregiver involvement, methodological quality, and outcomes reported. The 
majority of studies demonstrated statistically significant improvements in psychological 
outcomes of people living with PD. Interventions targeting depressive disorders in people 
living with PD were effective at reducing depression symptoms, and CBT was effective at 
reducing symptoms of anxiety. There was no substantive evidence to suggest dyad-based 
psychosocial interventions are effective for caregivers. 
Conclusion: Research of varied methodological quality suggest a role for psychosocial 
interventions for people living with PD, however, more high-quality research is required to 
conclusively establish the effectiveness of these interventions for both people living with PD 








Parkinson’s disease (PD) is the second most common neurodegenerative disorder 
primarily affecting people in the later years of their life.1 PD is predominantly caused 
by the death of dopamine producing cells within the brain.2 Dopamine has several 
functions as a neurotransmitter including regulating movement within the body. With 
the reduction in the production of dopamine, people living with PD develop several 
primary symptoms including slow movement, tremors and stiffness.2 PD motor 
symptoms can also be accompanied by nonmotor symptoms such as difficulties with 
sleep, mood, apathy, fatigue and cognition.3 As the disease progresses motor and 
nonmotor symptoms may worsen, resulting in a loss of independence.4 There is no 
known cure for PD, with current treatments primarily focused on reducing motor 
symptoms. However, the psychological impact of PD can be overlooked.5 Both 
primary symptoms of PD and the adjustment to living with a long-term health 
condition can affect the psychological wellbeing of people living with PD.6 
 
PD does not only impact on the people living with the condition, those supporting them 
may also experience psychological distress. Caregiver’s quality of life and 
psychological wellbeing can be negatively impacted by supporting those living with 
PD, and both motor and nonmotor symptoms associated with caregiver burden.7,8 As 
the disease progresses family members and partners commonly take on the role of 




interventions which consider the needs of both people living with PD and their 
caregivers are warranted. 
 
The prevalence of PD within the UK is predicted to increase by 56% by 2045,11 as a 
result there is a growing need to better understand how to support people living with 
PD and their caregivers. Especially considering that as the population is continuing to 
age, there is likely to be a greater number of older adults with long-term conditions 
such as PD with their family providing informal care. The potential impact this has on 
the current health and social services has not gone unnoticed. The recent integration 
of health and social care within Scotland was driven by the need to improve 
preventative and anticipatory care for service users, caregivers and families.12 
Psychosocial interventions may be an approach that could help meet the needs of this 
population. 
 
Researchers have explored the effectiveness of psychosocial interventions for people 
living with PD.5,13,14 Previous reviews have highlighted the limited research, however, 
studies that have been undertaken do indicate that psychosocial interventions may be 
effective in improving anxiety and depression.5,13 Yet the methodological quality of 
included studies may undermine reported benefits.13 Research has demonstrated that 
psychological outcomes such as quality of life and stress may also be impacted when 
living with PD.15 It would be beneficial to explore the effect of psychosocial 





A clinical review by Koychev & Okai14 explored the evidence for CBT in managing 
nonmotor symptoms of PD, specifically depression, anxiety, impulse-control disorders 
and insomnia. Authors found growing research for the use of CBT for managing 
nonmotor symptoms of PD, whilst also reviewing research of CBT interventions for 
caregivers of people with PD.14 However, there is a growing evidence-base for third 
wave therapies, such as compassion focused therapy (CFT) and acceptance and 
commitment therapy (ACT), in the management of neurodegenerative conditions for 
patients and caregivers.16,17 These have yet to be taken into consideration when 
assessing the effectiveness of psychosocial interventions for those impacted by PD. 
 
As previously discussed, it is also important to consider the psychological implications 
for those supporting people living with PD. Despite a growing evidence-base for 
psychosocial interventions for people living with PD, there has been limited research 
exploring the effectiveness of psychosocial interventions with caregivers of people 
living with PD.10 In 2008, Hempel et al.10 conducted a systematic scoping review of 
psychosocial interventions for caregivers of people living with PD. They found that 
caregivers were typically assigned the role of adjunctive therapist.10 Therefore, their 
own psychological needs were not necessarily the aim of the intervention. Research 
has demonstrated that the quality of life of people living with PD may be correlated 
with the emotional wellbeing of their caregiver.18 As a result, interventions that are 
delivered to people living with PD alongside their caregivers may be beneficial for 






Research within other long-term health conditions has demonstrated the benefits of 
dyad-based psychosocial interventions,19,20 with growing research within PD 
considering the needs of both people living with PD and their caregivers.21 Yet to-date 
no systematic review has focused on the effectiveness of dyad-based psychosocial 
interventions for people living with PD. 
 
Objective 
This systematic review aimed to evaluate the effectiveness of psychosocial 
interventions where both people living with PD and their caregivers are involved in 
the intervention, and psychological outcomes are evaluated for both caregiver and the 
person living with PD.  The research questions are as follow: 
 
• What are the effects of dyad-based psychosocial interventions on 
psychological outcomes of both people living with PD and their caregivers? 
• What are the effects of dyad-based psychosocial interventions on people living 
















This review included all people aged over 18 years. The participants included were 
people with a clinical diagnosis of PD and caregivers of people with a clinical 
diagnosis of PD. People with a diagnosis of secondary parkinsonism, Parkinson-plus 
or other neurodegenerative diseases were not included within this review. 
 
Intervention(s) 
Studies that evaluated the effectiveness of any psychosocial intervention which 
measured psychological outcomes of both people living with PD and caregivers of 
people with living PD were included. Psychosocial interventions which delivered their 
intervention to people living with PD and their caregivers were included. All formats 
of delivery of the psychosocial intervention were included e.g. individual, group, 
telephone etc. The psychosocial intervention was required to have focused primarily 
on psychological and/or social factors. In order to evaluate whether reported outcomes 
were the result of the psychosocial intervention, studies were excluded when the 
intervention included the addition of further therapies (i.e. exercise, occupational 






The review included studies with and without comparator groups. Studies with 
comparator groups were included, regardless of the type of comparators e.g. 
intervention control, waitlist control and treatment as usual. 
 
Outcome measure(s) 
Studies were included where psychological outcomes for both people living with PD 
and caregivers of people living with PD were taken at baseline and post intervention. 
Psychological outcomes reported by studies were varied e.g. anxiety, depression, 
quality of life, caregiver burden and caregiver distress. 
 
Study design(s) 
The review considered quantitative, qualitative and mixed-method study designs 
reported prior to November 2018. The review considered multiple study designs with 
no date limit set for the search, as previous research outlined limited literature within 
this area.5,10 The review included randomised controlled trials (RCTs), quasi-
experimental designs and case series. Published and grey literature were considered, 
with authors of grey literature being followed up for further information as required. 
Studies reported in English and studies reported in Spanish with an English abstract 
were included due to limited means to translate non-English language studies. 
 
Literature Search Strategy 
A search strategy was designed with consultation from a librarian experienced in 




searched from their inception date, however, research/trials published after October 
2018 were not included. The search was completed on the 3rd November 2018 using 
the following search terms: ((Parkinson*) AND (“psychosocial” or "psycho* 
intervention" or "cognitive behavio*" or “cbt” or "cognitive therap*" or 
“psychoeducation*” or "compassion focus* therap*" or "acceptance and commitment 
therap*" or "family therap*" or "mindfulness therap*" or "mindfulness* 
intervention*")).  
 
The following electronic databases were used; MEDLINE, PsycINFO, 
PsycARTICLES, ProQuest, Scopus, Teacher Reference Centre, Education Source, 
Cochrane Central Register of Controlled Trials (CENTRAL) (Cochrane Library), 
ERIC, EMBASE, ASSIA. In addition to the database search, references of included 
studies were reviewed, and searches on Google Scholar and PROSPERO were 
undertaken. No further records were identified by these means. 
 
Data Collection and Analysis 
 
Selection of Studies 
The studies resulting from the outlined search strategy were initially screened by their 
title and abstract against the PICOS criteria. Full articles where then further screened 
against the PICOS criteria. The first author completed the screening from the search 
to the included articles. Where articles could not be established by the first author 








The first author compiled the data from all included articles using a data extraction 
form designed for this review. The data extraction form was developed using guidance 
from the Centre for Reviews and Dissemination (CRD).23 Therefore, the data 
extraction form included the following; author, year of publication (recording whether 
published as a full-text or abstract only), study design, location of study, when the 
study was recorded, sample size of participants (including attrition), participant 
characteristics, intervention, nature of the control condition, treatment duration, 
follow-up period, analyses, number of participants included in the analyses, study 
outcomes (including primary and secondary outcomes), study sponsorship and main 
results (including effect sizes). Due to previous research demonstrating a heterogeneity 
of the delivery of interventions to both people with PD and caregivers within this 
area,5,10 in-depth details regarding the type, delivery, caregiver involvement and 
duration of the interventions were collected.  
 
Quality Assessment 
The Effective Public Health Practice Project Quality Assessment Tool (EPHPP) was 
used for quality appraisal,24 with two additional criteria designed for this study. The 
additional criteria were developed in line with the CRD recommendations. The EPHPP 
quality assessment tool provides a global rating,25 which is derived from the ratings of 




collection methods, and withdrawals and dropouts.  However, the additional ratings 
have been provided for the EPHPP components of analysis and intervention integrity, 
alongside the ratings for quality of reporting and generalisability designed specifically 
for this study. These four additional quality rated components may not contribute to 
the risk of bias, yet they are indicators of the methodological quality of the included 
studies. All criteria items were classified in terms of ‘strong’, ‘moderate’, ‘weak’ or 
‘not applicable’. The first author independently assessed all included articles, and the 
second author assessed 70% (n=9) of included articles using the quality assessment 
criteria. Kappa co-efficient for overall agreement of 0.76 was found, indicating 
adequate inter-rate agreement. Where there were discrepancies, these were discussed 
and amended if there was agreement. Agreement was found on all discrepancies, with 
the cause of discrepancies being primarily due to interpretation of the criteria. The first 





The electronic search identified 2142 unique results following removal of duplications. 
1925 search results were excluded at the stage of title and abstract screening. The main 
cause for exclusion at this stage was incorrect population and non-intervention studies. 
Following full review, a further 207 results were excluded. Authors of abstracts were 
also contacted to ascertain whether a full article was available (n=10). At full articles 
review, unsuitable intervention (n=103) and unsuitable outcomes (n=35) were the 




with information lacking regarding caregiver involvement, further information was 
sought from authors (n=3). In cases where data from the same sample were reported 
in duplicate articles, the most recent article was included (see Appendix 2). A final 13 
studies were included for qualitative synthesis. Figure 1 provides an overview of 
studies considered at each stage.  
 
Characteristics of Included Studies 
Thirteen studies were included for qualitative synthesis, summarised in Table 1. All 
studies had been published in peer-reviewed journals,26-37 except for one study which 
was an unpublished thesis project.38 Studies were conducted between 2003 and 2018. 
Five studies were carried out in Europe,26-28,35,37 seven carried out in North 





Figure 1. PRISMA Flowchart (adapted from Moher et al., 2009) 
*See Appendix 2.
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SD = Standard deviation, BELA-A-k = Belastungsfragebogen Parkinson kurzversion, BELA-P-k = Belastungsfragebogen Parkinson Angehorigen kurzversion, EQ-5D 
= EuroQol five dimension questionnaire, VAS = Visual Analogue Scale, PDQ-39 = Parkinson’s disease questionnaire (39 item), SDS = Self-rating Depression Scale, 
RCT = Randomised Control Trial, AES-S = Apathy Evaluation Scale-Self, MAQ = Multi-dimensional Anxiety Questionnaire, BDI-II = Beck Depression Inventory-II, 
AS = Apathy Scale, LASA = Linear Analogue Self-Assessment, ECOG = Everyday Cognition scale, PD-NMS = Parkinson’s disease Non-Motor Symptom Questionnaire, 
ZBI = Zarit Burden Inventory, ACT = Auditory Consonant Trigrams, DS = Digit Span, LNS = Letter Number Sequencing , CVLT-II = California Verbal Learning Test 
– II, CAR = cortisol awakening response, CBT = Cognitive Behavioural Therapy, HAM-A = Hamilton Anxiety Rating Scale, GAI = Geriatric Anxiety Inventory, IQAD 
= Informant Questionnaire for Anxiety in Dementia, HAM-D = Hamilton Depression Rating Scale, SF-36 = Medical Outcome Study 36-item Short-Form health survey, 
ICB = Impulse Control Behaviours, CGI = Clinical Global Impression, NPI = Neuropsychiatric Inventory, MDT = Multi-disciplinary Team, RCCT = Randomised 
Crossover Controlled Trial, UPDRS = Unified Parkinson’s disease Rating Scale, HADS = Hospital Anxiety and Depression Scale,  CSI = Carer Strain Index, IPT = 





Five of the included studies were RCTs.27,30,32,35,36 Control interventions included; 
treatment as usual,27,35 a neutral writing intervention,30 input from the General 
Neurologist,36 and close clinical monitoring.32 One study was a randomised controlled 
crossover trial including a waiting list control.37 Six studies used a quasi-experimental 




People living with PD: All studies included participants with a confirmed diagnosis of 
PD (n=13). Five studies required participants to have a psychiatric diagnosis in order 
to meet inclusion criteria. One study required diagnosis of anxiety31 and four studies 
required a diagnosis of depression.32-34,38 One study required participants to present 
with clinically significant impulse control behaviours (ICB).35 Sample sizes ranged 
from 3-151. Mean ages ranged from 59-71 years. Seven studies reported PD severity 
using the Hoehn and Yahr,39 with means ranging from 2.0-2.4.26-28,31-33,35 Two studies 
reported severity using the total score of the Unified Parkinson’s disease Rating Scale 
(UPDRS)40 with means ranging from 24.73-37.49.31,35 Nine studies described PD 
duration with means ranging from 4.3-10.1 years.27-29,32-36,38 
 
Caregivers: Ten studies provided detail of the involvement of caregivers in the 
intervention, and further information regarding caregiver input was sought from the 
authors of three studies.35-37 Sample sizes ranged from 3-137. Four studies provided 
demographic information regarding the caregivers,26-28,31 with mean ages ranging from 








Four studies delivered a CBT intervention31-34 and five studies delivered an 
intervention informed by CBT principles and/or strategies.26-29,35 One study delivered 
an expressive writing intervention30 with another delivering Interpersonal Therapy 
(IPT).38 One study provided multi-disciplinary team (MDT) input alongside group 
education,37 and one study provided specialist MDT which included Social Workers 
whose aim were to target psychosocial issues.36 
 
Participants living with PD were primary targets of the interventions within all 
included studies. Three studies delivered group interventions26-28 with an additional 
study including a group education component alongside specialist MDT input.37 Five 
studies delivered face-to-face individual interventions.31,32,35,36,38 Three studies 
intervention were delivered predominantly through telephone sessions.29,33,34 One 
study which evaluated an expressive writing intervention, was self-delivered.30 
 
Due to the variation of caregiver involvement, this was categorised in line with 
previous research exploring dyad-based interventions.41 The caregiver involvement 
was classified as a dyadic intervention (participants living with PD and their caregivers 
attend the intervention together), co-facilitating intervention (caregiver role is to 
support the participant living with PD during the intervention) or individual 




living with PD).41 Within this review it was identified that seven studies delivered a 
co-facilitating intervention for caregivers,32-38 four studies delivered individual 
interventions to caregiver,26-28,30 and only two studies described a dyadic 
intervention.29,31 
 
Appraisal of Methodological Quality 
Table 2 outlines the ratings of each study across all components assessed, components 
were rated either ‘strong’, ‘moderate’, ‘weak’ or ‘not applicable’. Details of which can 
be found in Appendix 3. Only two studies by Dobkin et al.32 and van der Marck et al.36 
received the EPHPP global rating of ‘strong’. This may be due to the methodological 
strength of design and quality of reporting. Compared to the other RCT studies, these 
two studies32,36 clearly described their process of randomisation reducing selection 
bias, demonstrated no significant differences between groups at base line, and blinded 
assessors to intervention group. However, due to possible selection bias and lack of 
participant blinding, there is still a potential for bias within these highest rated studies. 
Six studies received a global rating of ‘moderate’ due to lack of blinding of both 
assessors and participants in four of these studies,27-29,33,35 and one study experiencing 
more than 40% withdrawals and dropouts.37 The final five studies receiving a global 
rating of ‘weak’ were primarily due to lack of blinding,26,31,34,38 poor completion 
rate,26,31,34 or high risk of selection bias and confounding variables.30  It was also noted 
that three studies received a ‘weak’ rating for intervention integrity due to lack of 





Table 2. Methodological Quality Appraisal Ratings 



















A’Campo et al. 
200926 
2 2 N/A 3 1 3 3 3 2 2 1 
A’Campo et al. 
201027 
2 1 1 3 1 1 2 3 2 3 1 
A’Campo et al. 
201128 
2 2 N/A 3 1 2 2 3 2 2 1 
Butterfield et al. 
201729 
2 2 N/A 3 1 1 2 1  2 2 1 
Cash & Lagerman 
201530 
3 1 3 2 1 2 3 2 2 2 1 
Dissanayka et al. 
201731 
2 2 N/A 3 1 3 3 2 2 2 2 
Dobkin et al. 
2011a32 
1 1 1 2 1 1 1 1 1  1 1 
Dobkin et al. 
2011b33 
2 2 N/A 3 1 1 2 1 1 1 1 
Dobkin et al. 
201834 
2 2 N/A 3 1 3 3 2 1 2 1 
Okai et al.  
201335 
2 1 1 3 1 2 2 1 1 2 1 
van der Marck et 
al. 201536 
2 1 1 2 1 1 1 2 2 2 1 
Wade et al. 
200337 
2 1 1 2 1 3 2 2 2 2 1 
Rubino 201338 2 3 N/A 3 1 2 3 1 2 2 2 
1 = Strong; 2 = Moderate; 3 = Weak; N/A = not applicable; *EPHPP Global Rating derived from following components; selection bias, study design, confounders, 





Table 3 summarises the results of both the psychological and additional outcomes 
reported within the studies, with effect sizes described as reported. It was not 
considered appropriate for effect sizes to be calculated due to heterogeneity of studies 




Depression: Twelve of the studies assessed effectiveness of interventions on reducing 
depressive symptoms within participants living with PD.26,27,29-38 The two RCT studies 
assessed as having ‘strong’ methodological strength assessed effectiveness of reducing 
depression, one of studies delivered a CBT intervention32 and the other was a specialist 
MDT intervention.36 Both these studies found significant reductions in depressive 
symptoms in the intervention group compared to the control group, alongside large 
effect sizes found in the one study which provided effect sizes.32 Another RCT 
reported significant reduction in depressive symptoms in participants living with PD 
receiving a CBT-based intervention compared to the control group, with medium 
effect sizes at the 6 month follow-up.35 A further three studies of quasi-experimental 
design with mixed methodological quality also found significant improvements in 
depression post intervention.29,33,34 Similarly, an IPT case series reported clinically 
significant improvements with their two participants depressive symptoms.38 All of 
the included studies which required participants living with PD to have a diagnosis of 





The remaining four studies found no significant changes post intervention.26,27,30,31 The 
authors of two of these studies used the Self-rating Depression Scale which is yet to 
be validated, and they noted that there may have been a floor effect due to limited 
depressive symptomology at baseline.26,27 Alongside this, three of the studies which 
did not report any significant changes in depression had a global rating of ‘weak’ 
methodological quality.26,30,31 Therefore, poor outcome measures, selection bias or 
high attrition rate, may have impacted on the outcomes reported.  
 
Caregiver depression was evaluated in four studies delivering either CBT, CBT 
informed interventions or IPT.26,27,31,38 Authors of these studies similarly used 
unvalidated outcome measures and/or demonstrated areas of methodological 
weakness, of which none demonstrated any significant reductions in 
depression.26,27,31,38 
 
Anxiety: Seven studies reported outcomes of anxiety for participants living with PD.30-
35,37 Only one of the studies with ‘strong’ methodological quality, assessed 
effectiveness of their CBT intervention on reducing anxiety in people living with PD 
and found significant improvements in anxiety at the end of the intervention compared 
to the control group.32 This was also maintained at the four-week follow-up.32 A 
further four studies delivering CBT or CBT-informed interventions demonstrated 
significant improvements post intervention,31,33-35 however, two of these studies 
received ‘weak’ rating for methodological quality.31,34 Two studies reported no 
significant improvement with anxiety compared to control groups.30,37 Neither of these 




did not use an anxiety outcome measure demonstrated to be valid and reliable outcome 
measures of anxiety in people living with PD.30 Only one study reported outcomes of 
anxiety for caregivers, with no significant changes post intervention, however, this 
may be due to the high rate of dropouts and small sample size.31 Overall, dyad-based 
interventions which are derived from CBT appear to demonstrate effectiveness in 
reducing anxiety in people living with PD, whilst there is no quality research to draw 
conclusions regarding the effects for caregivers. 
 
Quality of Life: Twelve studies assessed quality of life pre and post intervention for 
people living with PD.26,27,29-38 All studies used at least one measure of quality of life 
which has demonstrated validity and reliability within people living with PD. Two 
RCTs with the strongest rating of methodological quality, a CBT intervention and a 
specialist MDT intervention, all found significant improvements in quality of life.32,36 
Three studies which delivered CBT-informed intervention found significant 
improvements,27,29,34 with two of these studies being rating as ‘moderate’ for their 
methodological quality.27,29 The further five studies found no significant 
improvements in quality of life for participants living with PD.26,30,31,33,37 The case 
series for IPT observed worsening of quality of life within one of the two participants 
who completed the IPT intervention.38 Considering that PD worsens with time, and 
research suggests that quality of life is associated with severity of PD,42,43 establishing 
the effect of an intervention without a control group for comparison is challenging. 
 
Three studies used the Eurqol-5d (EQ-5D) questionnaire,44 where authors described it 




perceived health more closely than quality of life.45 Therefore, the results of the EQ-
5D will be explored separately from the quality of life results previously outlined. One 
study used the EQ-5D with both participants living with PD and their caregivers, 
finding no significant difference post intervention.37 Correspondingly, two other 
studies found no significant changes for caregivers on the EQ-5D following the 
intervention.26,27 Thereby, suggesting that psychosocial interventions for people living 
with PD and their caregivers may not improve perceived health for both populations. 
 
Caregiver Specific Outcomes: Five studies assessed caregiver burden using the valid 
and reliable Zarit Burden Inventory46 and utilised a variety of designs and 
interventions.29-31,35,38 Four of the studies found no significant improvements and the 
further study observed improvements at post intervention which were not maintained 
at follow-up.31 One study assessed caregiver psychological outcomes using the 
Caregiver Strain Index,47 reporting no significant improvements between groups.36 
Three studies evaluated caregiver distress, using the Caregiver Distress Scale (CDS). 
The CDS was validated by an author of these studies and has not yet been assessed 
independently.32-34 Of the studies using the CDS, two found no significant 
improvements32,33 and one did find significant improvements.34 In summary, evidence 
would suggest that psychosocial interventions delivered to people living with PD and 
their caregivers do not lead to reduced burden and/or distress in the caregivers. 
However, considering the heterogeneity of the interventions, designs, quality of the 
studies and outcome measures across the studies, further research of high-quality is 





Additional Psychological Outcomes: Three studies explored apathy within participants 
living with PD.29-31 One study used the Apathy Evaluation Scale-Self,48 which found 
significant improvements within groups at post intervention and at one-month follow-
up.29 Two studies used the Starkstein Apathy Scale,49 neither of which found any 
significant improvements post intervention.30,31 
 
Two studies of ‘moderate’ quality delivering CBT interventions assessed coping styles 
in participants living with PD. Both studies found significantly greater use of positive 
reframing as a coping style following the intervention, with no significant change in 
the use of problem-focused coping.32,33 Three studies evaluated negative thoughts of 
participants with PD. The RCT delivering individual CBT found no significant 
difference between groups post intervention and at follow-up32 and the two quasi-
experimental studies delivering CBT through telephone found significant reduction in 
negative thoughts.33,34  
 
Psychosocial functioning was assessed in both participants living with PD and 
caregivers. When assessed in participants living with PD, two out of three studies 
assessing psychosocial functioning found significant improvements following 
interventions, however, the CBT intervention26 showed poor methodological quality 
compared to the specialist MDT intervention.36 Within participating caregivers, two 
of three studies found significant improvements of psychosocial functioning in 






One RCT assessed general psychiatric co-morbidity, finding significant reductions in 
both caregivers and participants living with PD within the CBT-informed intervention 
group compared to the control group at the 6-month follow-up.35 The primary aim for 
this study was to reduce impulse control behaviours (ICB) within participants living 
with PD. However, at time of delivering the intervention there were no known 
validated measures for ICB.35 As a result, the authors developed a measure specifically 
for the study, reporting significant reductions in ICB in the intervention group 
compared to the control group at follow-up.35  
 
For each additional psychological outcome assessed across the dyad-based 
psychosocial interventions included within this review, very few studies overlap in 
choice of outcomes and present with mixed findings. Some of studies used different 
outcome measures to assess the same psychological outcomes or used unvalidated 
measures for this population, therefore, limiting the comparison of the findings 
reported across these studies. Alongside this, many of the studies are of poor 
methodological quality. Therefore, caution is required when drawing conclusions 




Alongside a variety of psychological outcomes measured within the included studies, 
this review found that there were many additional outcomes assessed. Two studies 
assessed perceived inferential feedback using the Social Feedback Questionnaire, this 




validated.32,33 Authors reported no significant changes post intervention and at follow-
up for both these studies.32,33 Two studies measured both social functioning and quality 
of social support.35,38 Measures used to assess these outcomes differed in the RCT and 
case series. Significant improvements were only found for social functioning for 
participants living with PD in the RCT,35 and no significant changes were observed in 
caregivers when assessed.35  
 
Four studies assessed motor functioning, two of which were RCT’s which 
demonstrated strong methodological quality compared to the other studies.32,36 The 
authors of these higher quality studies found a significant improvement of motor 
functioning in the intervention group compared to the control group.32,36 It was unclear 
how long this effect lasted as no follow-up data were available for these studies. A 
further study found a significant improvement within group of motor functioning, 
which was maintained at the 3-month and 6-month follow-up.31 The final study 
assessing motor functioning, found no significant changes for the intervention group 
compared to the control group.37 Outcome measures used to measure motor 
functioning varied across these studies, however, all had been previously validated for 
people living with PD.50,51 
 
The overall severity of symptoms of PD was also assessed by several included studies. 
Two studies used either the UPDRS or Movement Disorder Society UPDRS total 
score, with one reporting significant improvement within group at post intervention 
and 3-month follow-up but not at 6-month follow-up,31 the other study reported 




post intervention.36 Another study used the Parkinson’s disease disability 
questionnaire to assess symptom severity and found that there was no difference 
between control and intervention groups post intervention, noting that all participants 
scores had worsened over the assessment period which is in keeping with the nature 
of a degenerative disease.37  
 
The effectiveness of interventions on sleep of participants living with PD was assessed 
by three studies. These studies used outcome measures which have been validated 
within the general population, however, are yet to be validated within a PD population 
(Pittsburgh Sleep Quality Index and Insomnia Severity Index). All studies assessing 
sleep found no significant changes following a CBT intervention.32,33,34 
 
Another study assessed common non-motor symptoms of PD using the valid and 
reliable Parkinson’s disease Non-Motor Symptom Questionnaire,3 and they reported 
no significant changes in these symptoms post intervention.30 This same study also 
assessed cortisol awakening response of participants living PD and their caregivers, 
and a multitude of cognitive abilities using numerous outcomes measures for 
participants living with PD (e.g. Everyday Cognition scale, California Verbal Learning 
Test – II, Montreal Cognitive Assessment, Standardized Mini Mental State 
Examination, Parkinson’s disease Cognitive Rating Scale, Informant Questionnaire on 
Cognitive Decline in the Elderly), on which there were no significant differences 





In summary, a wide range of additional outcomes were assessed across the included 
studies. Symptoms of PD, both motor and non-motor, were the most frequently 
assessed outcomes. There is mixed evidence on the effectiveness of the interventions 
on these outcomes. In addition, very few studies evaluated additional outcomes for 
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*p<0.05 **p<0.01, QoL = Quality of Life, ADL = acts of daily living, CAR = cortisol awakening response, HAM-A = Hamilton Anxiety Rating Scale, GAI = Geriatric 
Anxiety Inventory, IQAD = Informant Questionnaire for Anxiety in Dementia, MDS-UPDRS = Movement Disorder Society Unified Parkinson’s disease Rating Scale, 
CBT = Cognitive Behavioural Therapy, HAM-D = Hamilton Depression Rating Scale, BDI-II = Beck Depression Inventory-II, BC-PF = Brief COPE (Problem focused 
subscale), BC-PR = Brief COPE (Positive reframing subscale), CDS = Caregiver  Distress Scale, ICB = Impulse Control Behaviours, MDC = Multi-disciplinary Care, 






This review aimed to evaluate the effectiveness of psychosocial interventions as per 
the research questions, where both people living with PD and their caregivers are 
involved in the intervention, on psychological and any additional outcomes reported.  
 
In summary, this review indicated mixed support for the effectiveness of dyad-based 
psychosocial interventions upon the outcomes of participants living with PD, and 
limited evidence to suggest benefits for caregivers. The majority of included studies 
reported significant improvements on at least one psychological outcome for 
participants living with PD. However, due to the heterogeneity of outcomes reported, 
drawing conclusions on the effectiveness of the interventions on each psychological 
outcome assessed was limited. CBT or CBT-informed interventions were the most 
prominent dyad-based psychosocial intervention delivered, and demonstrated 
effectiveness in reducing anxiety symptoms in people living with PD. Similarly, dyad-
based psychosocial interventions which were specifically designed for people living 
with PD and an additional diagnosis of a psychiatric disorder all reported significant 
improvements in outcomes designed to assess reductions in symptoms of the 
psychiatric disorders. Taking in to consideration the majority of people living with PD 
presented with moderate PD, alongside the small sample sizes, caution should be taken 
when generalising the findings of these studies to the greater population of people 





Dyad-based psychosocial interventions which were designed to target psychiatric 
disorders in people living with PD, all showed effectiveness in relation to symptoms 
of the target psychiatric disorder. All four studies which were designed for people 
living with PD and a diagnosis of a depressive disorder, reported significant 
improvements in depressive symptoms following the interventions. This was 
demonstrated across studies regardless of the type or delivery of the intervention. It 
may be due to the interventions focusing on targeting known maintaining factors for 
depressive disorder that results in the improvements. Due to limited studies which 
were designed for other psychiatric disorders, alongside the poor methodological 
quality of these studies, further research would be required in order to understand 
whether diagnosis specific interventions are more beneficial than a transdiagnostic 
intervention for people living with PD. Notwithstanding, in line with previous 
research,4,13 this review provides further evidence of the effectiveness of psychosocial 
interventions for depression in people living with PD.  
 
Alongside depression, quality of life was one of the most frequent outcomes measured 
across the dyad-based psychosocial intervention studies included within this review. 
Many of the studies demonstrated improvements in quality of life for people living 
with PD, where others found no significant change. Quality of life is typically defined 
by the World Health Organisation as "a state of complete physical, mental, and social 
well-being not merely the absence of disease”.52(p1) Whilst the culture and values 
systems an individual lives within are required to be taken into consideration when 
understanding an individual’s quality of life.52 The broadness and complexity of the 




varied outcome measures were used across studies to assess quality of life in 
participants. The need to consider the many mental, social and physical factors of 
quality of life may also account for the broad range of additional outcome measures 
included across the studies, as these additional factors could contribute to an 
individual’s perceived quality of life e.g. sleep, social functioning, quality of 
relationships. As a result, a single outcome measure is restricted in how it can fully 
capture the quality of life of every individual, due to the subjective nature of this 
construct. Studies within this review may not capture all aspects of participants lives 
which they perceive to be relevant for better quality of life and could account for the 
mixed findings of this review. 
 
It is also important to contemplate the nature of PD when considering quality of life 
outcomes. Previous research has found that severity of illness is a main predictor for 
quality of life.42,43 Considering the nature of PD as a degenerative condition, it would 
therefore be expected that over time, quality of life deteriorates as the disease 
progresses. As reported, the majority of studies found either improvements or no 
significant changes in quality of life. Although no conclusive evidence was drawn 
from this review to suggest that dyad-based psychosocial interventions improve 
quality of life for people living with PD, it may be that these interventions may at least 
reduce the expected deterioration in quality of life. However, to establish whether this 
may be the case, further studies should include control groups and longer follow-up 
periods in order to establish whether dyad-based psychosocial interventions may either 





Similarly, when exploring additional outcomes assessed by the studies within this 
review, many assessed symptoms of PD using a wide range of outcome measures. As 
previously discussed, due to the nature of the disease it would be expected that 
symptoms of PD would continue to worsen over time. Yet, many studies either 
reported improvements or no significant changes following the intervention, in relation 
to both motor and non-motor symptoms of PD. Alongside a need to control for the 
disease progression, better consistency of outcome measures would be required to 
allow a valid comparison across studies. 
 
This review found very limited evidence regarding the effectiveness of dyad-based 
psychosocial interventions on caregiver outcomes. There was an observed lack of 
information gathered by studies in relation to caregiver demographics to account for 
confounding variables, alongside limited reporting on the involvement and adherence 
of caregivers to psychosocial interventions. Considering PD is not a discriminatory 
disease,53 it would be expected that caregivers may also be a diverse population e.g. 
ethnicity, socioeconomic status, gender etc. Therefore, being able to account for 
variations within the population may help identify whether there are certain subgroups 
which may either benefit, or not, from participating in a dyad-based psychosocial 
intervention. 
 
This review also found that caregivers tend to be included in psychosocial 
interventions in order to act as co-facilitators, in line with previous research.10 This 
highlights that although researchers recognise the potential benefit of included 




may not be designed with the needs of the caregivers at the forefront. This may result 
in limited consideration of the varied needs that caregivers may experience. On the 
other hand, due to the broad needs of caregivers (e.g. financial, social, emotional), 
psychosocial interventions may be limited in how they can address all these factors. 
 
One factor which could account for challenges in addressing the broad needs of 
caregivers, which was overlooked by many authors of included studies, is the 
relationship between caregivers and their care receivers. A spouse providing care to 
their partner may face different challenges compared to a child or friend. For example, 
some PD symptoms, such as sexual dysfunction and cognitive impairment, contribute 
to reduced marital satisfaction.54,55 However, participants raising concerns about 
intimate marital issues may be more challenging within heterogenous samples of 
caregivers or within group settings. Future studies should consider how best to tailor 
interventions to the needs of participating caregivers, whilst identifying whether they 
are more effective for homogenous groups of caregivers. 
 
This review does demonstrate that caregivers participating in dyad-based CBT or 
CBT-informed psychosocial interventions do not experience any detrimental effects. 
Within clinical practice it is not uncommon for people living with physical conditions 
to rely on the support of caregivers in order to attend health appointments. Therefore, 
involving caregivers may support the adherence of people living with PD to attending 





The most common types of dyad-based psychosocial intervention identified within this 
review were CBT or interventions informed by CBT principles and strategies. In line 
with previous reviews,5,13,14 CBT derived interventions demonstrated significant 
improvements of psychological outcomes post intervention for people living with PD, 
especially in reducing symptoms of anxiety.31-35 Alongside this, the CBT informed 
interventions within this review were delivered over 6-12 weeks. As a result, this 
review demonstrates that CBT derived dyad-based interventions can be appropriately 
adapted for people living with PD whilst being delivered within a limited time frame. 
Considering the restricted resources available within public funded health services, 
interventions derived from CBT for people living with PD may provide an economical 
and effective option within clinical practice. 
 
Overall, the methodological quality of the included studies was low. Although there 
were two studies which were identified to be of greater methodological quality, all 
studies were assessed to have at least one area for potential risk of bias. The main cause 
of concern contributing to poor quality were the design of the studies. The majority 
were quasi-experimental designs, resulting in risk of bias due to lack of blinding ability 
to account for confounding variables. Although the majority of outcome measures 
selected within the included studies were valid and reliable for the population, some 
studies also included measures developed by the authors and had not yet been 
independently assessed for people living with PD. The use of potentially unreliable 
measures may not measure the intended outcome and could account for the lack of 
significant effects within the outcomes. Overall, the quality appraisal of included 




conclusions regarding the effectiveness of dyad-based psychosocial interventions 
within people living with PD and their caregivers. 
 
Strengths and Limitations of Review 
This review identified thirteen papers through searching multiple databases. Although 
the research criteria to include caregiver outcomes within the interventions may have 
potentially reduced the number of articles included, the sample attained was in line 
with similar reviews with people living with PD.5,13 The inclusion of grey literature 
and no date restrictions within the search was identified as a strength, as it reduced the 
likelihood of publication bias. Conversely, due to limited resources only English and 
Spanish language studies were included.  
 
This review also aimed to identify studies which included interventions which have a 
growing field of research within health (e.g. CFT, ACT) albeit failing to identify any 
studies which met the inclusion criteria. It may be due to the strict exclusion criteria 
which prevented the inclusion of exercise therapies, that exercise interventions 
containing components of third-wave therapies may have resulted in the lack of these 
interventions being included. 
 
It should also be noted that this review did not specify that dyad-based psychosocial 
interventions required all participants living with PD to include their caregivers within 
the interventions. Due to this being omitted from the criteria, alongside the limited 
demographic information regarding caregivers presented within the studies, it was not 
possible to establish the difference between dyadic participation compared to 




of the criteria in order to reflect clinical practice, as there are incidences when 
participants living with PD and/or caregivers attend on their own, whether this may be 
due to commitments or preferences.  
 
Implications for Research 
The review has demonstrated that research of greater methodological quality is needed, 
whilst highlighting the importance of control groups and longer follow-up to account 
for disease progression and the impact this could have on reported outcomes. This 
study also highlights that future studies should utilise outcome measures that have 
demonstrated validity and reliability within people living with PD and caregivers, 
whilst developing consistency of chosen measures across future studies to allow for 
valid comparisons. As acknowledged, a range of outcomes may be required in future 
research to assess effectiveness of dyad-based interventions to account for the range 
of effects PD can have on both those experiencing the disease and their caregivers.  
 
This review also highlights the continued lack of consideration of the unique needs of 
caregivers within psychosocial interventions.10 Future studies require more detailed 
reporting regarding participating caregivers, to identify whether there are subgroups 
of caregivers who benefit from participating in a dyad-based psychosocial 
intervention. Information regarding differences between participants who participate 
as a dyad compared to alone could potentially identify subgroups of participants better 






In line with previous research, there appears to be a role for dyad-based psychosocial 
interventions for people living with PD. CBT and CBT-informed interventions 
continue to dominate this area of research, demonstrating effectiveness in improving 
psychological outcomes for people living with PD, especially reducing symptoms of 
anxiety. Dyad-based psychosocial interventions targeted for psychiatric disorders such 
as depression, also demonstrate effectiveness for people living with PD. However, as 
this review has highlighted mixed and sparse evidence of dyad-based psychosocial 
interventions on additional outcomes for people living with PD and reported outcome 
for caregivers, further research is still required within this area. 
 
Clinical Messages 
• Overall, dyad-based psychosocial interventions can produce statistically 
significant effects on psychological outcomes for people living with PD.  
• Dyad-based psychosocial interventions delivered to people living with PD and 
a diagnosed depressive disorder, may reduce symptoms of depression. 
• CBT derived interventions demonstrate effectiveness at reducing symptoms of 
anxiety in people living with PD. 
• Limited evidence was found to support the effectiveness of dyad-based 
psychosocial interventions for caregivers. 
• Further high-quality research is required, considering both traditional 
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Objective: This study extended previous research examining the relationship between illness 
beliefs and coping with psychological adjustment (in terms of anxiety, depression and quality 
of life) in people living with Parkinson’s disease (PD) and caregivers, whilst developing 
research into the role of self-compassion within this process. 
Design: A cross-sectional survey design with participants living with PD (N=66) and their 
caregivers (N=24) was utilised. 
Main Outcome Measures: Brief COPE, Brief-Illness Perception Questionnaire, Self-
Compassion Scale, Hospital Anxiety and Depression Scale, Parkinson’s disease Questionnaire 
8-item and Adult Carer Quality of Life Questionnaire. 
Results: Within a sample of people living with mild PD, greater coping responses and lower 
self-compassion were associated with greater levels of anxiety, perceiving PD to result in 
severe consequences was associated with greater levels of depression, and holding a strong 
illness identity was associated with poorer quality of life. Within the sample of caregivers, no 
independent predictors of psychological adjustment outcomes were found. 
Conclusion: Illness beliefs, coping responses and self-compassion may be associated with 
outcomes of psychological adjustment in people living with PD. Further research of a larger 
and more representative sample is required to establish the role of illness beliefs, coping 
responses and self-compassion with psychological adjustment in people living with PD and 
their caregivers. 









Parkinson’s disease (PD) is the second most prevalent neurodegenerative disease after 
Alzheimer’s disease. The prevalence is expected to continue to increase with rising 
life expectancy and resulting in a growing number of caregivers supporting those 
affected (Pringsheim et al., 2014). People living with PD can experience motor 
symptoms including tremors, stiffness and slow movement predominantly due to the 
death of dopamine producing cells within the brain (Bellucci et al., 2016). PD motor 
symptoms can also be accompanied by non-motor symptoms, including insomnia, 
apathy, fatigue and cognitive impairment (Martinez-Martin et al., 2013).  
 
Although advances in research have led to developments in pharmacological and 
surgical interventions which may manage these symptoms, there is no known cure. 
Due to the chronic and degenerative nature of the disease, symptoms worsen over time. 
Deterioration can result in wide ranging difficulties from loss in mobility, cognitive 
impairment, to difficulty communicating (Hsu et al., 2018). As a result, people living 
with PD may require increasing support from others. In many cases, it may be partners 
and family that provide care to those living with PD (Leiknes, Lien & Severinsson, 
2015). Living with PD impacts the quality of life (QoL) for both those with the disease 
and their caregivers (Dauwerse, Hendrikx, Schipper, Struiksma, & Abma, 2014; 
Kudlicka, Clare & Hindle, 2013). Therefore, the ability to cope and adjust over the 






Psychological adjustment is the psychological processes that people undertake when 
responding to chronic illness (Dekker & de Groot, 2018). The Common Sense Model 
(CSM) is an established approach to understand how people adjust to living with 
chronic illness (Leventhal, Phillips, & Burns, 2016). Developed by Leventhal and 
colleagues, the CSM proposes that beliefs people hold about illness guide their 
understanding and coping in relation to the illness. These representations of illness 
dictate coping actions, and as a result determine health outcomes such as psychological 
wellbeing and QoL. The following are the core ‘illness beliefs’ proposed by the model 
to be associated with health outcomes; ‘illness identity’ (attributing symptoms 
experienced to the illness), ‘consequences’ (impact of illness on life), ‘treatment 
control’ (whether treatment will help), ‘personal control’ (having control over the 
illness), ‘illness coherence’ (understanding of the illness), ‘timeline’ (how long the 
illness will last), and ‘emotional representations’ (emotional impact of the illness) 
(Hurt et al., 2014; Leventhal et al., 2016). 
 
Over the last decade, a small number of studies have explored the relationship between 
PD illness beliefs and indicators of psychological adjustment. A prospective study of 
people with PD by Evans and Norman (2009) found that illness beliefs of ‘personal 
control’, ‘emotional representations’ and ‘consequences’ were associated with higher 
levels of psychological distress (in terms of anxiety and depression). Only some of the 
measured illness beliefs were associated with psychological distress, and it may be that 
there is an overlap between the subscale of ‘emotional representation’ and the 
outcomes of anxiety and depression. Therefore, this study has provided limited support 




More recent studies have continued to explore the association between illness beliefs 
and outcomes of psychological adjustment, with varied findings. A cross-sectional 
study by Simpson, Lekwuwa and Crawford (2013) found that psychological outcomes 
were associated with the illness belief of ‘illness cause’ and ‘illness coherence’. 
Simpson et al. (2013) argued that the lack of consensus in illness belief predictors 
reported in their study and that of Evans and Norman (2009), may be due to Evans and 
Norman not testing the illness beliefs against more established predictors. Further 
research by Hurt el al. (2014) found that holding a strong ‘illness identity’ and negative 
‘emotional representations’ were associated with poor psychological wellbeing (in 
terms of anxiety and depression). They also found that illness beliefs of ‘illness 
identity’, ‘consequences’, ‘cyclical timeline’, and ‘illness coherence’ were associated 
with poor QoL. This research suggests that different illness beliefs may be associated 
with different outcomes of psychological adjustment, whilst contributing to the 
inconclusiveness of which illness beliefs are of importance in psychological 
adjustment in people living with PD.  
 
It should also be noted that none of the previous research discussed has explored the 
relationship between illness beliefs and psychological adjustment in caregivers (Evans 
& Norman, 2009; Hurt et al., 2014; Simpson et al., 2013). The illness beliefs caregivers 
have in relation to their care receivers’ illness has been explored in other 
neurodegenerative diseases, such as illness beliefs of ‘timeline’ and ‘consequences’ 
being associated with QoL in caregivers of people living with Huntington’s disease 




challenges, therefore, it would be beneficial to explore how caregivers adjust to 
supporting their care receiver living with PD. 
 
While there is limited research investigating the role of illness beliefs within 
psychological adjustment of caregivers, recent research has found that coping 
behaviours are predictors of psychological adjustment in both people living with PD 
and caregivers. A cross-sectional survey by Navarta-Sánchez et al. (2016) 
demonstrated that better psychological adjustment in people living with PD and 
caregivers was associated with having a greater number of coping responses. When 
considering the clinical implications of these findings, psychosocial interventions 
providing coping strategies may be beneficial for both people living with PD and their 
caregivers. Research has indicated that psychosocial interventions, predominantly 
Cognitive Behavioural Therapy (CBT), may be beneficial for people living with PD 
(Yang, Sajatovic, & Walter, 2012). Considering the role of cognitions and coping 
strategies in psychological adjustment, it is unsurprising that CBT may be beneficial 
for those living with PD. This is because CBT aims to help people learn helpful 
behavioural and cognitive strategies, including cognitive restructuring addressing 
unhelpful thoughts and beliefs. Yet, there is very limited evidence for interventions 
that help caregivers in adjusting to PD (see Chapter 1). Therefore, further research is 
required to better understand which factors contribute to psychological adjustment in 
both people living with PD and caregivers to inform how health professionals can best 





There has been growing research within health exploring the relationship between self-
compassion and psychological wellbeing. Compassion is described as ‘a sensitivity to 
suffering in self and others, with a commitment to try to alleviate and prevent it’ 
(Gilbert, 2014, p19). Furthermore, self-compassion is the compassion which you act 
towards yourself when faced with adversity (Terry & Leary, 2011). It has been 
established within non-clinical populations that those with greater self-compassion 
present with less psychological distress (Pinto-Gouveia, Duarte, Matos, & Fráguas, 
2013). Whilst in older people with poorer health, those who respond self-
compassionately to their difficulties perceive themselves to have greater well-being 
(Allen, Goldwasser, & Leary 2011).  
 
Within populations of people living with long-term health conditions, people with self-
compassion present with less psychological distress, and better QoL (Kenefick, 2016; 
Pinto-Gouveia et al., 2013; Wren et al., 2012). Greater self-compassion may also be 
associated with less psychological distress in caregivers. For example, a study of 
couples facing lung cancer found that less self-compassion was associated with greater 
psychological distress in both people living with cancer and their partners (Schellekens 
et al., 2017). Therefore, it would be important to consider what role self-compassion 
has in psychological adjustment to PD for people living with PD and their caregivers. 
 
Aims 
This study aimed to extend previous research examining the relationships between 




and their caregivers, whilst developing research in to the role of self-compassion. As 
a result, this study addressed the following questions: 
 
• Which illness beliefs are associated with psychological adjustment (in terms of 
depression, anxiety and QoL) in people living with PD and their caregivers?  
• Are greater number of coping responses associated with better psychological 
adjustment (in terms of depression, anxiety and QoL) in people living with PD 
and their caregivers? 
• Is self-compassion associated with better psychological adjustment (in terms 
of depression, anxiety and QoL) in people living with PD and their caregivers, 





This study used a cross-sectional survey design, using self-reported questionnaires to 
explore the relationships between coping responses, illness beliefs, self-compassion 
and psychological adjustment (in terms of anxiety, depression and QoL) in people 
experiencing the early stages of PD and their caregivers.  
 
Through the support of Parkinson’s UK Patient and Public Involvement, experts by 
experience reviewed the study design and research materials prior to ethical 






Ethical approval was granted by the National Health Service (NHS) Health Research 
Authority through the South West – Cornwall and Plymouth Research Ethics 
Committee, Reference Number 18/SW/0113 (See Appendix 5). NHS Research and 
Development approval was also granted by NHS Lothian as the study site. Participant 
identification centre (PIC) approval was granted by NHS Research and Development 
for NHS Tayside and NHS Lanarkshire (see Appendix 6).  
 
Eligibility of Participants 
Inclusion criteria for participants living with PD were as follows: (1) confirmed 
diagnosis of idiopathic PD at least 6 months prior to recruitment for the study; (2) 
identified by the referring health professional to present with mild PD; (3) meeting the 
criteria of stage 1 or 2 of the Hoehn and Yahr scale (Hoehn & Yahr, 1967); and (4) 
able to speak, read and write proficient English. Exclusion criteria for participants 
living with PD were as follows: (1) diagnosis of PD dementia and/or of mild cognitive 
impairment; (2) cognitive impairment which could negatively impact on their ability 
to provide informed consent and to understand and complete questionnaires; and (3) 
unwilling or unable to provide informed consent. 
 
Inclusion criteria for caregivers were as follows: (1) consents to participation in the 
study, the caregiver normally lives with the care receiver; (2) the caregiver is directly 
responsible for their care receiver’s care (for example they may provide physical 
and/or emotional support); and (3) over the age of 18 years. Exclusion criterion for 





All potential participants were identified across NHS Lothian, NHS Lanarkshire and 
NHS Tayside between November 2018 to June 2019. Within these health boards, 
people with PD who met the study criteria, were provided with information about the 
study by clinicians. Clinicians supporting the study were experienced in working with 
people with PD i.e. Parkinson’s Specialist Nurses, Neurologists and Specialist 
Physicians. Clinicians identified potential participants from their clinical case load. 
They initially discussed the study with their patients face-to-face or over the phone, 
prior to providing them with an information pack about the study (including a 
participant information sheet, consent form and stamped addressed envelope). 
Participants were recruited through the return of a completed consent form to the Chief 
Investigator (First Author), and in return a questionnaire pack was sent to the 
participant.  
 
Participants living with PD indicated through their consent form whether they 
consented to their caregiver participating in the study, which resulted in a caregiver 
information pack (including a participant information sheet, consent form and stamped 
addressed envelope) being posted to the participant for their caregiver. Caregivers 
provided consent by returning the completed consent form to the Chief Investigator 
(First Author) resulting in them being sent a questionnaire pack.  
 
Through the recruitment pathway outlined above, 71 completed consent forms were 
returned by participants living with PD and 67 questionnaires returned (94% return 




consented to a caregiver information pack being posted. 30 completed consent forms 
were returned by caregivers and 26 questionnaires returned (87% return rate).  
 
Materials 
The measures used are outlined below, which were completed by both participants 
living with PD and their caregivers unless otherwise stated. 
 
Demographic and Health Information 
A brief demographic and health information questionnaire was developed for 
participants living with PD to establish the following: age; gender; caregiver status; 
relationship status; employment; education; years since diagnosis of PD; comorbidity; 
medication; and socioeconomic status. The socioeconomic status was derived from the 
post codes provided by participants. Using the Scottish Index of Multiple Deprivation 
(SIMD) 2016, post codes were ranked by the SIMD decile rating, with 1 being the 
most deprived and 10 the least deprived (Scottish Government, 2016). 
 
Caregiver demographic and characteristics were established through the caregiver 
QoL measure, the Adult Carer Quality of life Questionnaire (ACQoL), later outlined 
(Joseph, Becker, Elwick, & Silburn, 2012). The demographic information gathered 
included: age; gender; hours providing caregiving; and years being a caregiver. 
 
Coping Responses 
The Brief COPE is a 28-item self-report questionnaire which measures different 




people living with PD and caregivers and has been shown to be a reliable and valid 
measure for caregivers and similar health populations (Navarta-Sánchez et al., 2016; 
Yusoff, Low, & Yip, 2010). The questionnaire is separated into the following 14 
subscales of coping behaviours: denial; venting; behavioural disengagement; 
substance misuse; positive reframing; planning; acceptance; religion; self-blame; self-
distraction; active coping; humour; use of emotional support; and use of instrumental 
support. In line with previous research, the total score provided was used for the 
analysis (Navarta-Sánchez et al., 2016). Analysis of each individual subscale was 
considered beyond the remit of this study. Cronbach’s alpha for the total coping 




The Brief-Illness Perception Questionnaire (Brief-IPQ) is a self-report questionnaire 
measuring a participant’s belief about their illness (Broadbent, Petrie, Main, & 
Weinman, 2006). Research has demonstrated the Brief-IPQ has good validity and test-
retest reliability (Broadbent et al., 2006). The Brief-IPQ statements are rated by 
participants on a Likert scale from 0-10, and each statement corresponds to the 
following dimensions; consequences, identity, treatment control, personal control, 
concerns, coherence, timeline and emotional representation (Broadbent et al., 2015). 
In line with similar research, the Brief-IPQ provided to caregivers adapted the phrase 
‘my illness’ to ‘your care receiver’s illness’ (Bassi et al., 2016). The subscale of 
‘emotional representation’ was not included in analysis due to potential overlap with 




not included within analysis due to previous research demonstrating this subscale to 
have poor validity and reliability (Moss-Morris et al., 2002; Simpson et al., 2013). 
 
Self-Compassion 
The Self-Compassion Scale (SCS) is a 26-item self-report scale of self-compassion 
(Neff, 2003). Research has demonstrated the measure to have good internal validity 
and test-retest reliability (Neff, 2003; Neff & McGehee, 2010; Przezdziecki et al., 
2013). The SCS covers 6 subscales (self-kindness, common humanity, self-judgement, 
over-identification, mindfulness and isolation), and provides a total score for self-
compassion. Participants answer each question on a 5-point Likert scale from ‘almost 
never’ to ‘almost always’ in relation to how they act towards themselves during 
difficult times. Cronbach’s alpha for the total self-compassion score in this study for 
the sample of participants living with PD was .87, and .95 for caregivers. 
 
Quality of Life 
Participants living with PD completed the Parkinson’s disease Questionnaire (PDQ-8) 
which measures QoL in people with PD (Peto, Jenkinson, Fitzpatrick, & Greenhall, 
1995). The PDQ-8 is a shortened version of the Parkinson’s disease Questionnaire 39-
item developed by Jenkinson, Fitzpatrick, Peto, Greenhall and Hyman (1997). 
Research has shown the PDQ-8 to be a valid and reliable measure of QoL (Tan, Lau, 
Au, & Luo, 2007). The PDQ-8 provides a total score, derived from eight subscales 
(activities of daily living, mobility, emotional wellbeing, stigma, cognitions, social 
support, communication, and bodily discomfort). Cronbach’s alpha for the total score 




Caregivers completed the ACQoL, a 40-item self-report questionnaire assessing QoL 
in caregivers (Joseph et al., 2012). The ACQoL demonstrates excellent consistency 
reliability (Joseph et al., 2012; Brand et al., 2016), and shown to be a valid tool within 
caregivers of stroke survivors (Mei, Lin, Li, Ding & Zhang, 2017). The ACQoL 
assesses eight subscales (sense of value, support for caring, money matters, caring 
choice, caring stress, ability to care, personal growth and carer satisfaction), which 
cumulate into a total score. Cronbach’s alpha for the total score in this study for the 
sample of caregivers was .94. 
 
Psychological Distress 
The Hospital Anxiety and Depression Scale (HADS) is a validated measure with good 
test-retest reliability (Snaith & Zigmond, 1986). It has been used within similar 
research exploring distress in people living with PD, as well as caregivers of people 
experiencing chronic illnesses (Evans & Norman, 2009; Marinus, Leentjens, Visser, 
Stiggelbout, & van Hilten, 2002; Schellekens et al., 2017). The HADS is a 14-item 
self-report questionnaire, half the items assess anxiety and half the items measure 
depression, providing total scores for each of these domains. Cronbach’s alpha for the 
total anxiety score in this study for the sample of participants living with PD was .85, 
and .82 for caregivers. Cronbach’s alpha for the total depression score in this for the 










Research exploring illness representations and coping responses in people living with 
PD has found medium effect sizes (Evans & Norman, 2009; Navarta-Sánchez et al., 
2016). Therefore, a priori calculation based on detecting a medium effect size, with a 
power of 0.8 and a significance of 0.05 was calculated using G*Power. This resulted 
in sample size of 92 participants living with PD required for the planned analysis. 
Similar research with caregivers has also demonstrated medium effect sizes, with 
fewer predictors (Kaptein et al., 2007; Navarta-Sánchez et al., 2016), and as a result 
77 was the sample size determined for caregivers. 
 
Missing Data 
Participants who had more than 20% of items missing per questionnaire were removed 
from analysis. This resulted in 4 participants being removed (participants living with 
PD = 1; caregivers = 3). Little’s Missing Completely at Random test was used to assess 
the pattern of missing values for the remaining participants across scales, results 
indicated data was missing at random. Analysis of missing data also found that less 
than 10% was missing per variable and therefore, the expectation-maximisation (EM) 
method was used to impute missing data. 
 
Planned Analysis 
The IBM Statistical Package for Social Sciences (SPSS) version 23 was used for data 




scores on all variables. Prior to correlational analysis, the presence of outliers was 
assessed for all variables. Violation of normal distribution was assessed prior to 
caregiver analysis due to the small sample size (Field, 2018). Where normal 
distribution was not found, log transformations were conducted (Field, 2018). If data 
did not present as normally distributed following transformation, then non-parametric 
Spearman’s correlation was undertaken.  
 
To identify any associations between demographics and measures of psychological 
adjustment (depression, anxiety and QoL), preliminary correlational analysis was 
undertaken using Pearson correlations and independent sample t-tests. Correlational 
analysis was also conducted to assess associations between predictor variables and 
each dependent variable using Pearson correlations and Spearman’s correlations. 
Variables found to be significantly associated with the dependent variable (depression, 
anxiety and QoL) were included within the hierarchical multiple regression models (p 
≤ 0.05). 
 
Hierarchical multiple regression was undertaken to assess for the additional variation 
accounted by illness beliefs, coping responses, and self-compassion for each of the 
psychological adjustment outcomes (depression, anxiety and QoL). Within each 
model, demographics found to be correlated with the outcomes were included firstly. 
In line with previous research, the more established predictors of illness beliefs were 
then added to the model, followed by coping responses if correlated, and finally self-
compassion was added. The coping responses total score was added after illness beliefs 




et al., 2016). Self-compassion was the last variable added to the model to assess its 
predictive power against more established predictors. Prior to running each regression 
model, analysis was undertaken to check for assumptions required (i.e. collinearity, 






Completed consent forms and questionnaires were returned by 67 participants living 
with PD and 27 of their caregivers. Accounting for missing data, 66 participants living 
with PD and 24 caregivers were included in analysis. Demographic and clinical 















Table 4. Demographic and Clinical Information of Participants living with PD 
Variable 
 
Mean (SD)  
or number (%) 
Age 68.65 (8.17) 
Gender  
  Female 
 
24 (36.4) 
Years in education 14.47 (5.45) 
Relationship status 
  Single 
  Married or cohabitating 
  Separated or divorced 







  No caregiver 
  Spouse is caregiver 
  Child is caregiver 







  Working (full or part time) 





  Deciles 1-3 
  Deciles 4-7 





Years since diagnosis of PD 4.55 (3.97) 
Comorbidity of other long-term health condition 59 (39) 
Receiving dopaminergic medication 60 (91) 




or number (%) 
Age 67.42 (7.22) 
Gender 
  Female 
 
14 (58.3) 
Years being a Caregiver 3.71 (2.54) 
Relationship to Care Receiver 
  Spouse 




Caregiving hours per week 
  ≤10 
  11-50 









Table 6. Means for Participants living with PD and Caregivers 











Min  Max 
IPQ Consequences 6.03 (2.61) 1 10 5.42 (2.78) 1 10 
IPQ Timeline 9.68 (.79) 6 10 9.46 (1.22) 5 10 
IPQ Personal control 4.42 (2.57) 0 10 2.75 (2.44) 0 9 
IPQ Treatment control 6.73 (2.35) 0 10 6.75 (2.03) 2 10 
IPQ Identity 5.74 (2.40) 1 10 3.38 (2.90) 0 8 
IPQ Illness concern 7.18 (2.52) 1 10 8.08 (2.30) 2 10 
IPQ Illness coherence 6.70 (2.41) 0 10 7.48 (1.78) 4 10 
Brief COPE Total 55.47 (10.12) 34 82 48.71 (8.30) 36 68 
SCS Total 84.67 (14.62) 53 124 85.29 (18.91) 40 116 
HADS Anxiety 7.23 (4.17) 0 18 6.25 (3.50) 0 13 
HADS Depression  6.41 (3.96) 0 18 4.08 (3.11) 0 10 
PDQ-8 32.67 (18.28) 3.13 75.00 - - - 
ACQoL - - - 76.25 (18.93) 28 107 
IPQ = Brief Illness Perception Questionnaire illness belief, SCS = Self-Compassion Scale, HADS = 
Hospital Anxiety and Depression Scale, PDQ-8 = Parkinson’s disease Questionnaire 8-item total score 
ACQoL = Adult Carer Quality of Life Questionnaire total score 
 
 
Means and standard deviations for predictors and outcome variables are presented in 
Table 6. Mean scores for anxiety were 7.23 (SD=4.17) for participants living with PD 
and 6.25 (SD=3.50) for caregivers. Means scores for depression for participants living 
with PD were 6.41 (SD=3.96) and 4.08 (SD=3.11) for caregivers. Scores ≥8 for each 
subscale of the HADS are recommended clinical cut-offs (Snaith & Zigmond, 1986). 
Whereas, scores ≥10 are the recommended clinical cut-offs for people living with PD 
on each subscale (Schrag et al., 2007; Leentjens et al., 2011). Therefore, 30% (n=22) 
of participants living with PD and 33% (n=8) of caregivers were within the clinical 
range for anxiety. Whilst 20% (n=13) of participants living with PD and 17% (n=4) 




living with PD was 32.67 (SD=18.28), with higher scores on the PDQ-8 indicating 
poorer QoL (max. score = 100). The mean QoL score for caregivers was 76.25 





Analysis was undertaken to establish demographic variables associated to dependent 
variables, to ascertain a need for their control in regression analysis. Pearson 
correlations for participants living with PD indicated there was a positive association 
between years since diagnosis and depression (r(66) = .25, p = .042), and a negative 
association between years since diagnosis and QoL (r(66) = .31, p = .011). Pearson 
correlations for caregivers indicated age was positively associated with QoL (r(24) = 
.46, p = .024). Years as a caregiver was positively associated with anxiety (r(24) = .67, 
p <0.001) and depression (r(24) = .53, p = .009). Whereas, years as a caregiver was 
negatively associated with QoL (r(24) = -.61, p = .002). As a result, these identified 
demographic and clinical predictors were included within the hierarchical multiple 
regression model when required. 
 
Correlation Analysis 
Correlation analysis was undertaken for predictor variables in both participants with 
PD and caregivers (see Table 7 and Table 8 respectively). Only variables which were 
found to be statistically associated with an outcome of psychological adjustment were 
included for further analysis within the hierarchical multiple regression models 




demographic variables previously outlined as being significantly associated with the 
outcomes of psychological adjustment. 
 







Years since PD diagnosis .029 (.819) .251* (.042) .311* (.011) 
IPQ Consequences .527** (.000) .599** (.000) .698** (.000) 
IPQ Timeline .168 (.179) .136(.276) -.019 (.883) 
IPQ Personal Control -.400** (.001) -.473** (.000) -.463**(.000) 
IPQ Treatment Control -.292* (.017) -.218 (.079) -.261* (.035) 
IPQ Identity .501** (.000) .532** (.000) .734** (.000) 
IPQ Illness Concern .518** (.000) .290* (.018) .444**(.000) 
IPQ Illness Coherence -.143 (.252) -.037 (.766) -.018 (.883) 
Brief COPE Total .341** (.005) -.058 (.642) .212 (.088) 
SCS Total -.454** (.000) -.458** (.000) -.433** (.000) 
*0.05 (two-tailed); **0.01 (two-tailed), IPQ = Brief Illness Perception Questionnaire illness belief, SCS 











Age -.229 (.281) -.089 (679) .458* (0.24) 
Years as caregiver1 .672** (.000) .525** (.009) -.608** (.002) 
IPQ Consequences .721* (.000) .540* (.007) .629** (.001) 
IPQ Timeline2 -.010 (.964) -.060 (.779) -.230 (.280) 
IPQ Personal Control -.497* (.014) -.359 (.085) -.574** (.003) 
IPQ Treatment Control -.419* (.041) -.280 (.186) .419* (.042) 
IPQ Identity .495* (.014) .431 (.036) -.473* (.020) 
IPQ Illness Concern1 -.247 (.244) -.201 (.347) .167 (.437) 
IPQ Illness Coherence -.233 (.274) -.047 (.828) -.016 (.942) 
Brief COPE Total .302 (.152) .284 (.178) -.329 (.116) 
SCS -.714** (.000) -.529** (.008) .826** (.000) 
1transformed (log); 2Spearman rho; *0.05 (two-tailed); **0.01 (two-tailed), IPQ = Brief Illness 






Hierarchical Multiple Regression Analysis 
Assumptions required for multiple regressions were assessed, all of which were met 
(i.e. collinearity, independent errors, normally distributed errors and standard 
residuals, and non-zero variances). Therefore, hierarchical multiple regression was 
conducted, using a model for each dependent variable (anxiety, depression and QoL).  
 
Predictors for Participants living with PD 
To understand predictor variables for anxiety in participants living with PD, 
hierarchical regression was conducted using three steps (see Table 9). In the first step, 
illness beliefs (consequences, personal control, treatment control, identity, and illness 
concern) were included, which accounted for 32.6% of variance in anxiety scores (R2 
= .378, adjusted R² = .326, p<.001). The second step added coping responses, 
accounting for an additional variance of 2.4% (R2 = .401, adjusted R² = .340, R² change 
= .024, p=.132). The final step added self-compassion, accounting for an additional 
variance of 5.3% (R2 = .454, adjusted R2 = .389, R2 change = .053, p=.021). Regression 
co-efficients exposed both total coping responses and self-compassion as significant 
independent predictor of total variance. Greater coping response was associated with 
more symptoms of anxiety (β = .098, t = 2.161, p = .035), and lower levels of self-
compassion were predictive of more symptoms of anxiety (β= -.080, t= -2.378, p= 
.021). Total variance accounted for by this model was 38.9%, F(7,58) = 6.903, p< .001. 
 
Hierarchical regression using three steps was conducted to understand predictor 
variables for depression in participants living with PD (see Table 10). The first step 




of depression (R2 = .063, adjusted R² = .048, p = .042). The second step added illness 
beliefs (consequences, personal control, identity, and illness concern) which accounted 
for an additional variance of 34.7% (R2 = .410, adjusted R² = .360, R² change = .347, 
p <.001). The final step added self-compassion, which accounted for an additional 
variance of 4.5% (R2 = .455, adjusted R² = .399, R² change = .045, p =.031). Regression 
co-efficient revealed the ‘consequences’ and self-compassion were independent 
variables of total variance of depression symptoms. With belief in more severe 
consequences of PD associated with greater levels of depressive symptoms (β = .674, 
t = 2.437, p = .018), and lower levels of self-compassion predictive of more severe 
symptoms of depression (β = -.067, t = -2.208, p = .031). The total variance accounted 
for by this model was 39.9%, F(6,59) = 8.198, p<.001. 
 
Hierarchical regression using three steps was conducted to understand predictor 
variables for QoL in participants living with PD (see Table 11). The first step included 
years since diagnosis of PD, which accounted for 8.3% of variance in QoL (R2 = .097, 
adjusted R² = .083, p =.011). The second step added illness beliefs (consequences, 
personal control, treatment control, identity, and illness concern), which resulted in an 
additional 48.7% variance (R2 = .584, adjusted R² = .542, R² change = .487, p <.001). 
The final step added self-compassion which accounted for an additional 0.7% variance 
(R2 = .591, adjusted R² = .542, R² change = .007, p =.311). The illness belief of 
‘identity’ was found through regression co-efficient to be an independent predictor of 
variance in QoL, with stronger illness identity associated with poorer QoL (β = 3.324, 
t = 2.848, p = .006). The total variance accounted for by this model was 54.2%, F(7,58) 




Table 9. Hierarchical regression to predict anxiety in participants living with PD 
Variable Β   B T p-value R R² ΔR² F for R² 
  Lower Upper Standardised      change 
Step 1       .614 .378 .326 7.280** 
IPQ Consequences .330 -.270 .929 .206 1.099 .276     
IPQ Personal Control -.087 -.537 .364 -.053 -.384 .702     
IPQ Treatment Control -.235 -.663 .192 -.133 -1.100 .276     
IPQ Identity .204 -.429 .837 .118 .645 .521     
IPQ Illness Concern .478 -.059 .897 .289 2.282 .026*     
Step 2       .633 .401 .340 2.339 
IPQ Consequences .295 -.300 .890 .185 .993 .325     
IPQ Personal Control -.163 -.620 .294 -.100 -.714 .478     
IPQ Treatment Control -.192 -.619 .235 -.108 -.900 .372     
IPQ Identity .159 -.470 .787 .091 .505 .615     
IPQ Illness Concern .411 -.013 .835 .249 1.940 .057     
Brief COPE Total  .069 -.021 .160 .168 1.529 .132     
Step 3       .674 .454 .389 5.655* 
IPQ Consequences .299 -.274 .873 .187 1.046 .300     
IPQ Personal Control -.096 -.540 .347 -.059 -.435 .665     
IPQ Treatment Control -.200 -.611 .212 -.113 -.972 .335     
IPQ Identity .005 -.614 .624 .003 .017 .986     
IPQ Illness Concern .284 -.138 .706 .172 1.349 .183     
Brief COPE Total  .098 -.007 .189 .238 2.161 .035*     
SCS Self-compassion -.080 -.147 -.013 -.281 -2.378 .021*     






Table 10. Hierarchical regression to predict depression in participants living with PD 
Variable Β   B T p-value R R² ΔR² F for R² 
  Lower Upper Standardised      change 
Step 1       .251 .063 .048 4.293* 
Duration of PD .250 .009 .491 .251 2.072 .042*     
Step 2       .640 .410 .360 8.810** 
Duration of PD .066 -.151 .283 .066 .608 .545     
IPQ Consequences .653 .082 1.223 .430 2.288 .026*     
IPQ Personal Control -.358 -.723 .007 -.232 -1.960 .055     
IPQ Identity .178 -.415 .760 .105 .587 .559     
IPQ Illness Concern -.160 -.560 .240 -.102 .802 .426     
Step 3       .674 .455 .399 4.874* 
Duration of PD .055 -.155 .266 .056 .527 .600     
IPQ Consequences .674 .121 1.228 .444 2.437 .018*     
IPQ Personal Control -.285 -.645 .076 -.184 -1.580 .119     
IPQ Identity .060 -.519 .639 .036 .208 .836     
IPQ Illness Concern -.248 -.644 .148 -.158 -1.254 .215     
SCS Self-compassion -.067 -.129 -.006 -.249 -2.208 .031*     








Table 11. Hierarchical regression to predict QoL in participants living with PD 
Variable Β Lower Upper B 
standardised 
T p-value R R² ΔR² F for R² 
change 
Step 1       .311 .097 .083 6.859* 
Duration of PD 1.433 .340 2.526 .311 2.619 .011*     
Step 2       .764 .584 .542 13.817** 
Duration of PD .444 -.412 1.301 .096 1.038 .303     
IPQ Consequences 1.563 -.699 3.794 .223 1.401 .166     
IPQ Personal Control -.556 -2.204 1.092 -.078 -.675 .502     
IPQ Treatment Control -.389 -1.952 1.175 -.050 -.497 .621     
IPQ Identity 3.530 1.229 5.831 .464 3.070 .003**     
IPQ Illness Concern .149 -1.415 1.714 .021 .191 .849     
Step 3       .769 .591 .542 1.043 
Duration of PD .421 -.437 1.279 .091 .983 .330     
IPQ Consequences 1.605 -.627 3.838 .229 1.439 .155     
IPQ Personal Control -.395 -2.073 1.283 -.055 -.471 .639     
IPQ Treatment Control -.435 -2.001 1.131 -.056 -.556 .581     
IPQ Identity 3.324 .988 5.660 .437 2.848 .006**     
IPQ Illness Concern -.017 -1.615 1.581 -.002 -.021 .983     
SCS Self-compassion -.126 -.373 .121 -.101 -1.021 .311     




Table 12. Hierarchical regression to predict anxiety in caregivers 
Variable Β   B T p-value R R² ΔR² F for R² 
  Lower Upper standardised      change 
Step 1       .706 .498 .475 21.817** 
Years as Caregiver .972 .540 1.403 .706 4.671 .000**     
Step 2       .841 .706 .625 3.197* 
Years as Caregiver .384 -.174 .941 .279 1.446 .165     
IPQ Consequences .477 -.058 1.011 .378 1.872 .078     
IPQ Personal Control -.296 -.732 .141 -.206 -1.424 .171     
IPQ Treatment Control -.382 -.895 .130 -.221 -1.566 .135     
IPQ Identity .104 -.301 .508 .086 .540 .596     
Step 3       .849 .720 .622 .814 
Years as Caregiver .304 -.288 .896 .221 1.083 .294     
IPQ Consequences .418 -.138 .974 .332 1.588 .131     
IPQ Personal Control -.223 -.694 .248 -.155 -.999 .332     
IPQ Treatment Control -.343 -.868 .181 -.199 -1.380 .185     
IPQ Identity .085 -.325 .495 .070 .463 .668     
SCS Self-compassion -.034 -.112 .044 -.183 -.917 .372     








Table 13. Hierarchical regression to predict depression in caregivers 
Variable Β   B T p-value R R² ΔR² F for R² 
  Lower Upper Standardised      change 
Step 1       .592 .350 .321 11.860** 
Years as Caregiver .722 .287 1.157 .592 3.444 .002**     
Step 2       .612 .375 .315 .025* 
Years as Caregiver .517 -.124 1.159 .424 1.678 .108     
IPQ Consequences .257 -.330 .844 .230 .910 .373     
Step 3       .630 .397 .307 .732 
Years as Caregiver .414 -.280 1.109 .340 1.245 .227     
IPQ Consequences .181 -.440 .802 .162 .608 .550     
SCS Self-compassion -.034 -.116 .048 -.205 -.856 .402     











Table 14. Hierarchical regression to predict QoL in caregivers 
Variable Β   B T p-value R R² ΔR² F for R² 
  Lower Upper standardised      change 
Step 1       .785 .616 .580 16.849** 
Age 1.109 .371 1.848 .423 3.123 .005**     
Years as Caregiver -4.751 -6.846 -2.656 -.639 -4.716 .000**     
Step 2       .861 .742 .651 2.078 
Age .913 .070 1.755 .348 2.284 .036*     
Years as Caregiver -2.377 -5.296 .541 -.320 -1.719 .104     
IPQ Consequences -2.115 -4.986 .755 -.311 -1.555 .138     
IPQ Personal Control .960 -1.761 3.680 .123 .744 .467     
IPQ Treatment Control 2.103 -.602 4.808 .225 1.641 .119     
IPQ Identity -.153 -2.360 2.054 -.023 -.146 .886     
Step 3       .885 .784 .689 3.063 
Age .505 -.435 1.444 .192 1.139 .271     
Years as Caregiver -1.463 -4.445 1.519 -.197 -1.040 .314     
IPQ Consequences -1.168 -4.123 1.787 -.172 -.838 .414     
IPQ Personal Control .875 -1.709 3.458 .113 .718 .483     
IPQ Treatment Control 1.508 -1.157 4.174 .161 1.199 .248     
IPQ Identity -.246 -2.343 1.851 -.038 -.249 .807     
SCS Self-compassion .378 -.079 .823 .372 1.750 .099     




Predictors for Caregivers 
To understand predictor variables for anxiety in caregivers, hierarchical regression 
using three steps was conducted (see Table 12). In the first step, years as a caregiver 
was included, accounting 47.5% of variance in anxiety scores (R² = .498, adjusted R² 
= .475, p < .001). The second step included illness beliefs (consequences, personal 
control, treatment control, and identity) for analysis, which resulted in an additional 
variance of 20.9% (R² = .706, adjusted R² = .625, R² change = .209, p =.038). The final 
step added in self-compassion, which accounted for an additional 1.4% of variance (R² 
= .720, adjusted R² = .622, R² change = .014, p =.372). Regression co-efficients 
revealed no independent predictors variables for total variance of anxiety symptoms. 
The total variance accounted for by this model was 62.2%, F(6,17) = 7.297, p =.001. 
 
Hierarchical regression using three steps was conducted to understand predictor 
variables for depression in caregivers (see Table 13). Within the hierarchical 
regression model exploring depression, the first step included years as a caregiver, 
which accounted for variance of 32.1% (R² = .359, adjusted R² = .321, R² change = 
.350, p =.002). The second step added illness beliefs (consequence) for analysis, which 
accounted for variance of 2.5% (R² = .375, adjusted R² = .315, R² change = .025, p 
=.373). The final step added in self-compassion, which accounted for an additional 
2.2% of variance (R² = .397, adjusted R² = .307, R² change =.022, p =.402). Regression 
co-efficient analysis highlighted no independent predictors of variance for depression. 





Hierarchical regression using three steps was conducted to understand predictor 
variables for QoL in caregivers (see Table 14). The model firstly included age and 
years since as caregiver, which accounted for 58% of variance in QoL (R2 = .616, 
adjusted R² = .580, p<.001). The second step added illness beliefs (consequences, 
personal control, treatment control, identity) which resulted in additional 12.6% of 
variance (R2 = .742, adjusted R² = .651, R² change = .126, p =.129). The final step 
added self-compassion resulting in an additional 4.1% variance (R2 =.784, adjusted 
R² = .689, R² change = .041, p =.099). Regression co-efficient analysis highlighted no 
independent predictors of variance for QoL. The total variance accounted for by this 
model was 68.9%, F (7,16) = 8.276, p<.001. 
Discussion 
This study aimed to explore whether illness beliefs and coping responses have an 
association with psychological adjustment (in terms of depression, anxiety and QoL) 
in people living with PD and their caregivers. In addition, this study aimed to explore 
the role of self-compassion in psychological adjustment for people living with PD and 
caregivers. 
 
Results indicated illness beliefs accounted for significant variance in anxiety for both 
participants living with PD and caregivers, as well as depression and QoL for 
participants living with PD. The only illness beliefs found to be independent predictors 
were ‘consequences’ and illness ‘identity’ in participants living with PD. With 
participants living with PD who perceive their illness to have more significant 
consequences, experiencing more severe symptoms of depression. Whereas, those 




participants living with PD are consistent with Evans and Norman (2009) who found 
illness beliefs to explain significant variance in depression and anxiety scores, 
alongside the illness belief of ‘consequences’ being an independent predictor of 
depression symptoms. Similarly, the illness belief of ‘identity’ being associated with 
QoL is also in line with previous research (Hurt et al., 2014).  
 
The findings of this study, alongside previous research (Evans & Norman, 2009; Hurt 
et al., 2014), indicate that some of the core illness beliefs outlined by the CSM may 
not be of relevance for those affected by PD. Equally, this research could indicate a 
minority of key illness beliefs are of more importance in the early stages of PD. The 
CSM describes a dynamic process with illness beliefs being continually appraised, 
therefore, future longitudinal research could identify if other core illness beliefs are of 
more importance in psychological adjustment as PD progresses. 
 
This study also found greater coping responses only accounted for additional variance 
in relation to anxiety of participants living with PD, differing from previous research 
demonstrating greater coping responses predict better psychological adjustment 
(Navarta-Sánchez et al., 2016). The findings of this study may contrast with those of 
Navarta-Sanchez et al. (2016), due to their lack of controlling for additional and more 
established predictors when analysing the association between coping responses and 
psychological adjustment. Research in people living with PD indicate anxiety is 
associated with maladaptive coping strategies, such as avoidance and resignation 
(Evans & Norman, 2009). Therefore, the association between anxiety and greater 




of maladaptive coping responses. This highlights that more importance should be 
placed on each coping responses’ success at reducing psychological distress, rather 
than on the extent to which people are engaging in coping strategies.  
 
Self-compassion was found as an independent predictor for symptoms of anxiety and 
depression in people living with PD. The findings support previous research which 
found better psychological wellbeing in those with more self-compassion (Wren et al., 
2012; Pinto-Gouveia et al., 2013; Schellekens et al., 2017). It is theorised that self-
compassion regulates negative emotions (Finlay-Jones, 2017). This may account for 
participants living with PD with greater self-compassion experiencing less symptoms 
of anxiety and depression. 
 
The complexity of the construct of QoL may account for the lack of association 
between self-compassion and QoL. Research indicates that QoL for people living with 
PD are influenced by a wide range of interacting factors unique to each person 
(Dauwerse et al., 2014). It is possible that there could be a subgroup of people living 
with PD whose perceived QoL may be associated with self-compassion. To identify 
whether this is the case, qualitative research may be well placed to take into 
consideration the broad factors which contribute to QoL (e.g. relationship quality, 
communication, and culture), and their relationship with self-compassion. 
 
This study also explored the role of self-compassion in caregivers, albeit finding no 
association. The scores on measures of psychological adjustment were low for 




compassion. This might partly be due to recruiting people within the mild stages of 
PD, where less day-to-day support may be required resulting in lower levels of distress 
for caregivers. Future research would require recruiting caregivers of people 
experiencing different severities of the condition to ascertain whether self-compassion 
may be of benefit as the demands of caregivers increase. A recent qualitative study by 
Vatter et al. (2018), exploring female caregivers experiences of supporting their 
spouses living with PD, found that as cognitive impairment declined and dementia 
began to emerge. The authors also found greater time was spent caregiving alongside 
the caregiver’s marital satisfaction declining significantly (Vatter et al., 2018). As a 
result, future research which explores psychological adjustment across the PD needs 
to account for additional factors associated with psychological outcomes e.g. nature of 
relationship and quality of relationship. 
 
Further consideration of the mutual benefits of self-compassion within psychological 
adjustment is also required. For example, research in other health conditions found 
that high self-compassion of a spouse may compensate for their partners low self-
compassion, resulting in decreased distress for both (Schelleken et al., 2017). Previous 
studies have disregarded the benefits of including caregiver outcomes alongside 
people living with PD, preventing dyadic exploration of data (Evans & Norman, 2009; 
Hurt et al., 2014; Simpson et al., 2013). This study did consider the importance of 
caregivers in the adjustment of living with PD, yet, it was not possible to explore 
dyadic interactions due to the limited sample size. Future research should include 
caregivers to allow for individual and dyadic analysis to identify which factors 




Strengths and Limitations of Study  
To the authors knowledge, this study is the first to explore the role of self-compassion 
in the adjustment to PD, for both people living with PD and their caregivers. This study 
also adds to the understanding of the role of illness beliefs and coping within the 
process of psychological adjustment. However, results need to be considered within 
the limitations of this study. Firstly, the cross-sectional design, although feasible 
within the limited timeframe and resources available, does not allow for conclusions 
to be drawn between the relationship of predictors and outcomes of psychological 
adjustment. 
  
Another limitation of the study was the sample size recruited. The number of 
participants living with PD recruited was similar to previous research (Evans & 
Norman, 2009), yet there were difficulties recruiting the calculated sample size, 
especially for caregivers. It was noted that 68% (n=48) of participants living with PD 
consented for a caregiver to participate, limiting the pool of caregivers to recruit from. 
As a result, it was not possible to reach a sample size large enough to reduce the risk 
of type I and type II errors occurring. 
 
The limited number of caregivers identified and recruited may be due to people within 
the early stages of PD not identifying themselves as receiving emotional and/or 
physical support from those close to them, due to less severe symptoms. A lack of 
consistent reporting of PD severity within the NHS regional boards meant the inclusion 
of severity as a predictor within the analysis was not feasible. This was considered as 




al., 2012; Hurt et al., 2014; Navarta-Sánchez et al., 2016). To allow for the greatest 
sample, this study recruited only people experiencing mild PD, as similar research 
found those who chose to participate predominantly presented with mild PD (Navarta-
Sánchez et al., 2016). Consequently, excluding participants living with moderate to 
severe PD may have contributed to difficulties reaching the planned sample sizes, 
whilst limiting the ability to generalise findings to participants living with greater 
severity of PD and their caregivers.  
 
Clinical Implications 
This study found that illness beliefs may account for variation in psychological 
adjustment in both people living with PD and their caregivers. However, there appears 
to be variance in which illness belief may indicate better psychological adjustment. 
Therefore, a formulation-based approach may be the best way for health professionals 
to ascertain whether certain illness beliefs are contributing to poor adjustment within 
both people living with PD and their caregivers. Within this approach, exploring 
patient’s identity in relation to their illness, alongside their perception of the 
consequences of their condition, is of importance due to their association with 
psychological distress. Due to the chronic nature of PD, unsurprisingly there may be a 
perception of severe consequences and attribution of their symptoms to their condition. 
Therefore, it is important that services can provide education about PD in the early 
stages of the condition. This study also highlights that some people living with mild 
PD may be struggling to adjust to their diagnosis and could benefit from specialised 




As this study suggests both illness beliefs and self-compassion contribute to 
psychological distress in people living with mild PD, psychosocial interventions which 
address these factors may be beneficial for this population. CBT may be able to address 
illness beliefs which are contributing to poor psychological adjustment through 
cognitive restructuring. CBT also has growing evidence for its effectiveness in 
reducing anxiety and depression in people living with PD (Yang et al., 2012). 
However, CBT does not aim to address self-compassion, which this study has also 
shown to be associated with psychological distress. 
 
Interventions which address self-compassion should be considered for those who may 
not have benefited from more established approaches for psychological distress e.g. 
pharmacology and CBT. One such intervention demonstrated to increase self-
compassion is CFT (Leaviss & Uttley, 2015). Gilbert (2009) conceptualised CFT 
within a framework of the evolution of affect regulation systems. These systems have 
evolved in order to keep mammals safe and seek resources (Gilbert, 2014). CFT 
focuses on three systems; the ‘threat’ system recognises and responds to threats, the 
‘drive’ system provides information to motivate resource seeking, and the ‘soothing’ 
system provides information on safety to activate rest and contentment (Gilbert, 2009). 
CFT aims to address imbalances within these systems, helping individuals initiate their 
‘soothing’ system through self-compassion to respond to threats (with the ‘threat’ 
system associated with emotions such as anxiety and anger) (Leaviss & Uttley, 2015). 
It could be proposed that people living with PD may be vulnerable to difficulties in 
both ‘drive’ and ‘threat’ systems. Alongside the common symptom of anxiety 




apathy, potentially indicating deficits in the ‘drive’ system due to the depletion of 
dopamine (Muhammed et al., 2016). Further exploration of the interaction between 
apathy, psychological distress and self-compassion may help identify whether CFT 
can provide a unique approach to tackle imbalances of affect regulation systems in 
people living with PD. In the meantime, CFT should be considered for people living 
with PD who are experiencing significant psychological distress. 
 
Within the wider context, the Scottish Government is in the process of approving the 
‘5-year National Action Plan on Neurological Conditions’, aimed to provide the best 
care and support for both people living with neurological conditions and their 
caregivers (Scottish Government, 2018). This will offer the opportunity for those 
affected by PD, public services and the third sector to develop innovative approaches 
for better care. This research highlights that people living with mild PD and their 
caregivers may experience significant levels of psychological distress. Therefore, 
approaches which meet the psychological needs of this population should be a key 
consideration in future service development. 
 
Conclusions 
This study provides further evidence for the relationship between illness beliefs and 
psychological adjustment outcomes in people living with PD, whilst providing 
preliminary evidence of a relationship between outcomes of psychological adjustment 
(depression and anxiety) and self-compassion. However, due to the nature of the 
design of the study and limited sample size, conclusions cannot be drawn. Future 




understand how self-compassion, coping strategies and illness beliefs may benefit 
people living with PD and their caregivers over the course of the condition. 
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Appendix 3. Quality Appraisal Tools and Scoring 
 
The Effective Public Health Practice Project (EPHPP) Quality Assessment Tool was 
used in full, with rating undertaken as guided within the EPHPP dictionary. Both the 





The intervention integrity and analysis components within in the EPHPP were 
provided ratings, however, these ratings did not impact on the Global Rating for the 
EPHPP. Two additional quality appraisal components to assess quality of reporting 
and generalisability were designed for this study. The following outlines how ratings 





STRONG More than 80% of participants received the allocated 
intervention AND consistency of the intervention was measured 
AND unlikely that participants received an unintended 
intervention 
MODERATE More than 60% of participants received the allocated 
intervention AND unlikely that participants received an 
unintended intervention 
WEAK Less than 40% of participants received the allocated intervention 




STRONG Statistical methods appropriate for the study AND intention-to-
treat analysis undertaken 
MODERATE Statistical methods appropriate for the study 




QUALITY OF REPORTING 
 
Adherence to statement guidelines for reporting (CONSORT for RCT’s, TREND for 
nonrandomised designs, STROBE for observational designs) 
 
STRONG Reporting of the article strictly followed the relevant statement 
guideline. 
MODERATE Reporting of the article covers all required sections outlined by 
the guidelines, however, some aspects outlined in guidelines 
missing but these aspects would not impact on assessing risk of 
bias and replication of the study. 
WEAK Does not appear to follow the guidelines and/or does not report 
on major sections required by the guidelines. 
NOT 
APPLICABLE 
Study design does not require that it adheres to guidelines 
(TREND, CONSORT and STROBE). 
 
GENERALISABILITY 
Intervention implemented in a way that would be considered routine practice for this 
population 
 
STRONG The settings where the participants were recruited and delivered 
from were representative of the settings where an intervention 
would be received e.g. recruitment settings include 
clinical/community setting and delivery setting include 
clinical/community/home setting. 
MODERATE The article discusses generalisability to a clinical/community 
setting, however, does not take place in these settings. 
WEAK The article does not discuss generalisability AND intervention 
takes place within a setting not considered routine practice (e.g. 
research) or setting not reported. 
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